Physician

Margaret Yap Curran, M.D.

According to 2025 Medicare claims, Margaret Curran, M.D. (NPI: 1629149364) practices rheumatology in the Spartanburg, SC market, with the plurality of this provider's patient population coming from Spartanburg, SC. This provider's primary affiliated billing organization is ARTICULARIS HEALTHCARE GROUP INC. (NPI: 1083696413; TIN: 571099718) and primary practice location at 29303-4210. Curran is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Curran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 105,989 HCPCS/CPT codes, and received $1,353,310 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,377 prescription claims across 338 beneficiaries totaling $3,351,657 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 112 records totaling $2,760. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,526 to $1,353,310. Similarly, Part D prescription costs have moved sharply higher in recent years, from $8,297 to $3,351,657. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	12	2,175	$9,526
2019	77	7,181	$204,694
2020	222	25,628	$627,480
2021	263	43,934	$832,559
2022	246	68,194	$977,565
2023	249	98,713	$1,168,209
2024	235	105,989	$1,353,310

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	29	66	$8,297
2019	127	661	$193,546
2020	245	1,456	$518,362
2021	335	2,025	$1,485,446
2022	334	2,268	$2,081,254
2023	342	2,391	$3,183,622
2024	338	2,377	$3,351,657

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	201	511	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	190	413	$13
80053	Blood test, comprehensive group of blood chemicals	184	372	$10
86140	Measurement c-reactive protein for detection of infection or inflammation	195	404	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	196	409	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	94	2,864	$911,664
Enbrel Mini	Etanercept	58	1,764	$475,551
Enbrel Sureclick	Etanercept	55	1,540	$416,432
Cosentyx Sensoready (2 Pens)	Secukinumab	21	588	$182,056
Xeljanz	Tofacitinib Citrate	26	780	$148,566

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$2,760	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Margaret Yap Curran, M.D.?

Tedicare shows public-source Medicare data for Margaret Yap Curran, M.D. (NPI 1629149364), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Margaret Yap Curran, M.D. have ACO affiliation data?

Margaret Yap Curran, M.D. is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Margaret Yap Curran, M.D.?

Margaret Yap Curran, M.D. is linked to ARTICULARIS HEALTHCARE GROUP INC. (billing NPI 1083696413) in the available physician profile data.

Does Margaret Yap Curran, M.D. have Open Payments data?

Margaret Yap Curran, M.D. has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.